279 related articles for article (PubMed ID: 16822686)
1. Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center.
Ouattara H; Siransy-Bogui L; Fretz C; Diane KM; Konate S; Koidio A; Minga KA; Hyda J; Koffi-Abe N; Offoumou AM; Abissey S
Transfus Clin Biol; 2006 Oct; 13(4):242-5. PubMed ID: 16822686
[TBL] [Abstract][Full Text] [Related]
2. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
3. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
4. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
Seed CR; Kiely P; Keller AJ
Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
[TBL] [Abstract][Full Text] [Related]
5. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
6. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
[TBL] [Abstract][Full Text] [Related]
7. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
8. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Fearon MA; Allain JP
Vox Sang; 2012 Jul; 103(1):83-6. PubMed ID: 22289147
[TBL] [Abstract][Full Text] [Related]
9. Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing.
Alvarez do Barrio M; González Díez R; Hernández Sánchez JM; Oyonarte Gómez S
Euro Surveill; 2005 Feb; 10(2):20-2. PubMed ID: 15735311
[TBL] [Abstract][Full Text] [Related]
10. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ
N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512
[TBL] [Abstract][Full Text] [Related]
11. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
Shang G; Seed CR; Wang F; Nie D; Farrugia A
Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
[TBL] [Abstract][Full Text] [Related]
12. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
Pillonel J; Laperche S; ; ;
Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
[TBL] [Abstract][Full Text] [Related]
13. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
Koch C; Araújo F
Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
[TBL] [Abstract][Full Text] [Related]
14. Risk behaviors in volunteer blood donors who seroconverted for HIV, Abidjan, Côte d'Ivoire 1997 to 2005.
Minga A; Dohoun L; Abo Y; Coulibaly A; Konaté S; Ouattara HP; N'guessan BK; Dabis F; Salamon R; Lewden C;
Transfusion; 2010 Apr; 50(4):888-93. PubMed ID: 19951316
[TBL] [Abstract][Full Text] [Related]
15. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003.
Niederhauser C; Schneider P; Fopp M; Ruefer A; Lévy G
Euro Surveill; 2005 Feb; 10(2):14-6. PubMed ID: 15735314
[TBL] [Abstract][Full Text] [Related]
16. [Routine PCR screening for HBV, HCV and HIV-I genome in a large blood donation services--experiences and initial results].
Schottstedt V; Tuma W; Bünger G; Lakenberg P
Beitr Infusionsther Transfusionsmed; 1997; 34():21-5. PubMed ID: 9417342
[TBL] [Abstract][Full Text] [Related]
17. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
[TBL] [Abstract][Full Text] [Related]
20. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
